Mediterr J Rheumatol 2018;29(2):86-8
Patient with ankylosing spondylitis and scleroderma renal crisis
Authors Information

Department of Pathophysiology, Medical School, University of Athens, Athens, Greece

  1. Distler J H, Schett G, Gay S, Distler O. The controversial role of tumor necrosis factor alpha in fibrotic diseases. Arthritis Rheum 2008;58:2228-35. https://doi.org/10.1002/art.23645.
  2. Chua C C, Chua B H: Tumor necrosis factor-alpha induces MRNA for collagenase and TIMP in human skin fibroblasts. Connect Tissue Res 1990;25:161-70.
  3. Mauviel A, Daireaux M, Redini F, Galera P, Loyau G, Pujol J P: Tumor necrosis factor inhibits collagen and fibronectin synthesis in human dermal fibroblasts. FEBS Lett 1988;236:47-52.
  4. Liu J Y, Brass D M, Hoyle G W, Brody A R.TNF-alpha receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers. Am J Pathol 1998;153:1839-47.
  5. Phumethum V, Jamal S, Johnson S R. Biologic therapy for systemic sclerosis: a systematic review. J Rheumatol 2011;38:289-96.
  6. Stewart F A, Gavino A C, Elewski B E. New side effect of TNF-alpha inhibitors: morphea. Skinmed 2013;11:59-60. PubMed PMID: 23540081.
  7. Ramírez J, Hernández M V, Galve J, Cañete J D, Sanmartí R. Morphea associated with the use of adalimumab: a case report and review of the literature. Mod Rheumatol 2012;22:602-4. https://doi.org/10.1007/s10165-011-0550-4. Epub 2011 Nov18. Review. PubMed PMID: 22095405.
  8. Mattozzi C, Richetta A G, Cantisani C, Giancristoforo S, D'Epiro S, Gonzalez Serva A, et al. Morphea, an unusual side effect of anti-TNF-alpha treatment. Eur J Dermatol 2010;20:400-1. https://doi.org/10.1684/ejd.2010.0946. Epub 2010 Mar 19. PubMed PMID: 20299314.
  9. Bosello S, De Santis M, Tolusso B, Zoli A, Ferraccioli G. Tumor necrosis factor-alpha inhibitor therapy in erosive polyarthritis secondary to systemic sclerosis. Ann Intern Med 2005;143:918-20.
  10. Olivieri I, Gemignani G, Balagi M, et al. Concomitant systemic lupus erythematosus and ankylosing spondylitis. Ann Rheum Dis 1990;49:323e4.
  11. Lee J K, Jung S S, Kim T H, Jun J B, Yoo D H, Kim S Y. Coexistence of ankylosing spondylitis and mixed connective tissue disease in a single patient. Clin Exp Rheumatol 1999;17:263.
  12. Kotevoglu N. Coexistence of ankylosing spondylitis and Behcet’s disease. Two cases with atypical presentation and course. Scand J Rheumatol 2003;32:184e5.
  13. Ouédraogo D D, Palazzo E, Nlomé-Nzé M, Somogyi-Demerjian N, Meyer O. Ankylosing spondylitis and systemic sclerosis: a rare combination. Joint Bone Spine 2009;76:290-2.
  14. Soledade C S, Sampaio-Barros P D, Samara A M, Marques-Neto J F. Unusual association of systemic sclerosis and ankylosing spondylitis. Clin Rheumatol 2005;24:652-4.
  15. Kayser C, Alvarenga M C, Neves A S, Gerbase-De Lima M, Andrade L E. Severe ankylosing spondylitis and diffuse systemic sclerosis: case report of a genetic trap. Scand J Rheumatol 2005;34:145-7.